(Q36723412)

15 August 2017

1 reference

title

Markers of angiogenesis and clinical features in patients with sarcoma (English)

1 reference

15 August 2017

1 reference

Steven DuBois

1

1 reference

15 August 2017

George Demetri

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

15 August 2017

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

15 August 2017

volume

109

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

813-819

1 reference

Targeting angiogenesis for the treatment of sarcoma

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Angiogenesis and antiangiogenic approaches to sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Angiogenesis in malignant fibrous histiocytoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Microvessel density does not predict outcome in high grade soft tissue sarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Metalloproteinase expression and prognosis in soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Gelatinase and inhibitor expression in soft tissue sarcomas: lack of correlation with distant metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Patterns of expression and secretion of vascular endothelial growth factor in malignant soft-tissue tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Serum endostatin levels are elevated in patients with soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Prognostic relevance of increased angiogenesis in osteosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Tumor angiogenesis and outcome in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

The neuropilins and their role in tumorigenesis and tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Quantification of angiogenesis stimulators in children with solid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Microvasculature and VEGF expression in cartilaginous tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Expression of basic fibroblast growth factor and its receptor in angiosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22455

7 January 2021

Identifiers

DOI

10.1002/CNCR.22455

1 reference

15 August 2017

1 reference